A Phase I PK/PD Study of PEG-MetHuG-CSF (P2203) in Healthy Volunteers

NCT06698861 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

PK in Healthy Volunteers

Interventions

DRUG: PEG-MetHuG-CSF
DRUG: Neulasta (Amgen)

Sponsor

PharmaEssentia

Collaborators

[object Object]